Investigation Overview
March 24, 2016 (Shareholders Foundation) - An investigation on behalf of investors of SAGE Therapeutics Inc (NASDAQ:SAGE) shares over potential securities laws violations by SAGE Therapeutics and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the secu...
You must register (for free) or login to view the entire investigation.